ABO and Alzheimer disease: This time point was chosen to cover the period of switching from acute to chronic pathology and to fulfill the gap of knowledge regarding the tissue pathology between short-term (24 h–7 days) responses to AβO infusion [7, 14, 25] and well-described time-dependent AD progression for various Tg animals, commonly started from 3 months of age [46].